NCT00471588View on ClinicalTrials.gov

Characterize The Modulatory Effects Of Dopamine D2/D3 Receptor Agonist And Antagonist Drugs On Compulsive Behaviors

PHASE1CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

Obsessive-Compulsive Disorder

Interventions

DRUG

Pramipexole, Amisulpride

Study Drug

Trial Locations (1)

CB2 0QQ

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY